Physostigmine- and 1,1-dimethyl-4-phenylpiperazinium-induced pressor responses and catecholamine release in 6-hydroxydopamine-treated rats.
D000311:Adrenal Glands / Q000098:blood supply / Q000378:metabolism / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism*; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004347:Drug Interactions; D004837:Epinephrine / Q000032:analysis / Q000494:pharmacology; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D008297:Male; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis / Q000097:blood / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000502:physiology
D002395:Catecholamines; D005731:Ganglionic Stimulants; D010879:Piperazines; D004246:Dimethylphenylpiperazinium Iodide; D010830:Physostigmine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine